These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11140157)

  • 1. [Amoral--or only hopelessly backward? Arguments against the condemnation of conventional neuroleptics. Invitation to discussion].
    Finzen A
    Psychiatr Prax; 2000 Nov; 27(8):365-6. PubMed ID: 11140157
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuroleptics in the newspaper. A mass media analysis].
    Hoffmann-Richter U; Wick F; Alder B; Finzen A
    Psychiatr Prax; 1999 Jul; 26(4):175-80. PubMed ID: 10457969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From neuroleptics toward antipsychotics: quality of life and schizophrenia].
    Lançon C
    Encephale; 2003 Sep; 29(Pt 2):S43-6. PubMed ID: 14710537
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fewer adverse effects! Treatment with atypical neuroleptics].
    Müller N; Riedel M
    Pharm Unserer Zeit; 2002; 31(6):558-65. PubMed ID: 12481513
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atypical neuroleptics--a heterogenous group. Valuable option in acute psychoses].
    MMW Fortschr Med; 2002 May; Suppl 2():85. PubMed ID: 12070863
    [No Abstract]   [Full Text] [Related]  

  • 6. [From neuroleptics toward antipsychotics: practice of changing the treatment, choice of the time and disputes, clinical aspects].
    Plas J
    Encephale; 2003 Sep; 29(Pt 2):S40-2. PubMed ID: 14710536
    [No Abstract]   [Full Text] [Related]  

  • 7. [The course of schizophrenic psychoses treated with neuroleptics].
    Rüther E; Nedopil N; Strauss A
    MMW Munch Med Wochenschr; 1981 May; 123(19):803-4. PubMed ID: 6112707
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of neuroleptics on the social behavior disorders of schizophrenic patients].
    Mahé V
    Encephale; 2003 Sep; 29(Pt 2):S28-30. PubMed ID: 14710533
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of schizophrenia with "atypical antipsychotic drugs". Quality of life as a measure of treatment success].
    Krankenpfl J; 2002; 40(7-9):230-1. PubMed ID: 12514869
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychopharmacologic treatment issues.
    Kane JM
    Psychiatr Med; 1990; 8(1):111-24. PubMed ID: 1974078
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of schizophrenia].
    Bitter I
    Orv Hetil; 2004 Jun; 145(24):1281-3. PubMed ID: 15264758
    [No Abstract]   [Full Text] [Related]  

  • 12. [What information do patients with schizophrenia have about their illness and treatment?].
    Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
    Encephale; 2000; 26(5):30-8. PubMed ID: 11192802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication nonadherence may lead to hospitalization.
    J Psychosoc Nurs Ment Health Serv; 2003 Aug; 41(8):10. PubMed ID: 13677006
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clozapine in the treatment of schizophrenia].
    Raitasuo V
    Duodecim; 2000; 116(11):1199-204; quiz 1205. PubMed ID: 11989005
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride.
    Linden M; Scheel T; Eich FX
    J Psychopharmacol; 2006 Nov; 20(6):815-23. PubMed ID: 16401647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Schizophrenia].
    Finnish Psychiatrists' Association
    Duodecim; 2001; 117(24):2640-57. PubMed ID: 12183827
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic principles for differential therapy of psychoses].
    Hell D; Bridler R
    Praxis (Bern 1994); 2001 May; 90(22):975-80. PubMed ID: 11450185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for long-acting antipsychotic agents in the post-CATIE era.
    Nasrallah HA
    Acta Psychiatr Scand; 2007 Apr; 115(4):260-7. PubMed ID: 17355516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential lower efficacy of molindone among first-generation antipsychotics.
    Waugaman RM
    Am J Psychiatry; 2009 Apr; 166(4):491; author reply 492-3. PubMed ID: 19339370
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
    Kane JM
    J Clin Psychiatry; 2003; 64 Suppl 19():3-5. PubMed ID: 14728083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.